Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

China’s ZDG Options Canadian Medical Devices in a Potential Blockbuster Deal

publication date: Nov 8, 2013
Zhongguancun Development Group (ZDG), a state-owned science and technology investment company, signed an unusual 45-day exclusive option for seven medical devices that are being developed by Canada’s Medical Devices Innovation Institute (MDI). The option will allow ZDG to receive only preliminary information on each device. To get more details, ZDG will have to pay an additional $7 million. To see working prototypes, ZDG must invest somewhere between $500 million and $700 million. ZDG is affiliated with Beijing's Zhongguancun Science Park. More details...

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital